Cardiac Drugs Flashcards
1
Q
adenosine: class
A
- antidysrhythmic
- naturally occurring nucleotide
2
Q
adenosine: MOA
A
- decreases automaticity of SA node and slows conduction thru AV node
- inhibits cyclic AMP induced calcium influx, so suppresses calcium dependent action potentials in the SA and AV nodes
3
Q
adenosine: Indication
A
- termination of paroxysmal SVT–more emergent use
- including Wolff Parkinson White Syndrome
- test drug during stress test in cardiac cath lab
4
Q
adenosine: SE
A
- dyspnea (from bronchoconstriction)
- hypoTN
- facial flushing (from vasodilation)
- chest comfort (from stimulation of pain receptors in the heart)
5
Q
adenosine: ADRs
A
- sinus bradycardia
- seizures
- stroke
- MI
- ventricular tachycardia
6
Q
adenosine: nursing implications
A
- ADRs/SEs are minimal and last less than 1 minute b/c the drug is cleared rapidly from the blood
- asthma pts taking certain meds (ie. theophylline) need a larger dose of adenosine b/c those meds block adenosine Rs and even then the adenosine may not work
- short half life (<10 sec), so must give by IV bolus
- watch for orthostatic hypoTN and bronchospasm in asthmatics
- 6 second flat line
- hold arm above pt when administer
7
Q
digoxin: class
A
- antidysrhythmic
- cardiac glycoside
- inotropic
8
Q
digoxin: MOA
A
- positive inotropic actions: their ability to inc myocardial contractile force
- can inc CO
- works by inhibiting Na/K ATPase, so inhibits the uptake of K into the cell which inhibits Na moving out, so w/ each action potential, intracellular K declines, Na inc, and Ca inc, so promotes Ca accumulation in myocytes
- dec conduction thru AV node by:
- direct depressant effect on AV node
- acting on CNS to inc parasympathetic impulses to AV node
- dec automaticity of SA node by :
- inc parasympathetic traffic to node
- dec sympathetic traffic
9
Q
digoxin: indications
A
- HF
- control of dysrhythmias
- SVT
- atrial fibrillation/flutter: can slow ventricular rate by reducing atrial impulses thru AV node
- ineffective against ventricular dysrhythmias
10
Q
digoxin: SEs
A
- GI disturbances: anorexia, nausea, vomiting, discomfort
- CNS: fatigue, visual disturbances
11
Q
digoxin: ADRs
A
- cardiotoxicity: dysrhythmias
- risk inc by hypokalemia which can result from concurrent therapy with diuretics (thiazides and loop diuretics)
- risk inc by presence of heart dz
12
Q
digoxin: nursing implications
A
-
watch K+ levels especially in pts taking thiazide or loop diuretics
- must be w/in normal ranges: 3.5-5.0 mEq/L
- need to monitor these–digoxin toxicity
-
narrow therapeutic range, so need to keep range b/w 0.5-0.8 ng/mL
- half life is 36-48 hours
- make sure pts don’t double up on doses to compensate for missed dose
- limit salt intake to 1500 mg/day
- pts should avoid excess fluid
- if drink alcohol, consume no more than 1 drink/day
- help pts establish appropriate regular, mild exercise
- teach pt to monitor pulse
- HR must be over 60 bpm before administration
- teach pt to monitor for signs of hypokalemia (muscle weakness)–inform doctor
13
Q
verapamil: class
A
- antidysrhythmic
- nondihydropyridine calcium channel blocker (class IV)
14
Q
verapamil: MOA
A
- slowing of SA nodal automaticity
- delay of AV nodal conduction
- reduction of myocardial contractility
- blockade of peripheral arterioles which causes dilation and reduces arterial pressure
- blockade of arteries and arterioles which inc coronary perfusion
- vasodilation
15
Q
verapamil: indications
A
- atrial fibrillation w/ RVR or flutter
- b/c slow ventricular rate
- AV nodal reentrant circuit
- so terminates SVT–more long term than adenosine
- essential HTN
- angina pectoris
- NOT effective against ventricular dysrhythmias